NEWARK, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (Nasdaq: RAIN) (“Rain”), today announced it has entered into a definitive merger agreement whereby Pathos AI, Inc. (“Pathos”) will acquire Rain for $1.16 in cash per share plus a non-tradeable contingent value right (a “CVR”) for potential cash payments of up to approximately $0.17 per share.
Penny stocks to buy according to insiders.
The post 3 Top Penny Stocks to Buy According To Insiders In October appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.